Categories: Market

MINDCURE Announces Financial Results for the First Quarter of Fiscal 2023

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”)  announced its financial results for the three months ended August 31, 2022.  All amounts are stated in Canadian dollars unless otherwise indicated.  

The special committee of the Company’s board of directors is continuing to explore, review and evaluate a broad range of strategic alternatives with its strategic review process. The Company’s cash position and balance sheet remain strong and the Company looks forward to finding the best path forward for all shareholders.

A copy of the Company’s financial statements for the three months ended August 31, 2022 and the related management’s discussion and analysis are available under the Company’s profile on SEDAR at

Larissa Chaikowsky has resigned as a director of the Company’s board of directors effective November 1, 2022.  While the special committee of the Company’s board of directors continues to consider strategic alternatives, a replacement will not be appointed.  “On behalf of the board of directors and the Company, I would like to thank Larissa for her contribution and support.  Her commitment and insight were very much appreciated by the board and management. ” stated Philip Tapley, CEO and Chair of the board of directors of MINDCURE.


Published by

Recent Posts

Staffordshire University team make shortlist at higher education Oscars

Staffordshire University’s Library and Learning Services team has been shortlisted for an award at the…

7 months ago

Nidec Signs Joint Venture Agreement with Norwegian Semi-Solid Lithium-Ion Battery Manufacturer FREYR Battery

On August 30, 2022 (Japan Standard Time), Nidec Corporation (“Nidec”) (TSE: 6594; OTC US: NJDCY)…

7 months ago

Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing…

7 months ago

Venus Concept Announces Second Quarter of Fiscal Year 2022 Financial Results; Updates Fiscal Year 2022 Revenue Guidance

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology…

7 months ago

Moberg Pharma and Padagis sign agreement for MOB-015 in Israel

Moberg Pharma AB (OMX: MOB) has signed a distribution agreement with Padagis Israel Agencies Ltd.…

8 months ago

NNT and Polygiene team up to create new frontline workwear uniforms for health professionals

If you work in a high-pressure environment, you want to feel fresh and comfortable. When…

8 months ago